Daniel A. Haber
36Patents
9h-index
53Co-inventors
78Inventor score
Filing activity: Nov 20, 1991 → May 27, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7294468B2 | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments | Physics | 165 | Expired |
| US8105769B2 | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments | Physics | 91 | Active |
| US7964349B2 | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments | Physics | 87 | Active |
| US5350840A | Localization and characterization of the Wilms' tumor gene | Chemistry; Metallurgy | 84 | Expired |
| US8465916B2 | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments | Physics | 81 | Active |
| US5726288A | Localization and characterization of the Wilms' tumor gene | Physics | 33 | Expired |
| US6177248A | Downstream genes of tumor suppressor WT1 | Emerging Cross-Sectional Technologies | 25 | Expired |
| US6316599A | Localization and characterization of the Wilms' tumor gene | Physics | 19 | Expired |
| US6258536A | Expression monitoring of downstream genes in the BRCA1 pathway | Chemistry; Metallurgy | 15 | Expired |
| US10140422B2 | Progression analytics system | Physics | 6 | Active |
| US9035036B2 | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments | Physics | 5 | Active |
| US10872131B2 | Progression analytics system | Physics | 4 | Active |
| US10053692B2 | Methods relating to circulating tumor cell clusters and the treatment of cancer | Chemistry; Metallurgy | 2 | Active |
| US10596162B2 | Method for treating gefitinib resistant cancer | Human Necessities | 2 | Active |
| US10603314B2 | Method for treating gefitinib resistant cancer | Human Necessities | 2 | Expired |
| US11371101B2 | Digital analysis of blood samples to determine efficacy of cancer therapies for specific cancers | Chemistry; Metallurgy | 1 | Active |
| US10731162B2 | Methods relating to circulating tumor cell clusters and the treatment of cancer | Chemistry; Metallurgy | 1 | Active |
| US11898209B2 | Digital analysis of circulating tumor cells in blood samples | Chemistry; Metallurgy | 1 | Active |
| US9417244B2 | Cadherins as cancer biomarkers | Physics | 1 | Active |
| US8652786B2 | Method for predicting responsiveness to drugs | Chemistry; Metallurgy | 0 | Active |
| US6943011B2 | Localization and characterization of the Wilms' tumor gene | Physics | 0 | Expired |
| US10900083B2 | Methods and assays relating to circulating tumor cells | Physics | 0 | Active |
| US10301624B2 | Targeting human satellite II (HSATII) | Chemistry; Metallurgy | 0 | Active |
| US11142800B2 | Biomarkers of cancer | Chemistry; Metallurgy | 0 | Active |
| US12331363B2 | Digital analysis of blood samples to determine efficacy of cancer therapies for specific cancers | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.